As previously mentioned, DMG display low expression levels of immune checkpoint proteins, however, studies suggest CAR T-cell administration might cause an upregulation of these proteins, even though this is yet to be investigated in DMG.100,101 On a positive note, combining CAR T therapy with PD-1 inhibition has shown positive results in GBM. This evidence concerns the gene PDCD1 and glioblastoma.